Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.6% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. CRDO
8. OIG
9. SPY
10. SNDX

Go back to Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.6% Yield

Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA)

January 22, 2020 9:21 AM EST

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with Teva Pharmaceuticals, USA (NYSE: TEVA) resolving patent litigation brought in response to Tevas abbreviated new drug application (ANDA) seeking approval to market generic versions of 145 mcg and 290 mcg LINZESS (linaclotide) prior to the expiration of the companies applicable patents. This settlement with Teva is the last of the remaining defendants in this patent... More

Wells Fargo Downgrades Allergen (AGN) to Equal Weight

January 22, 2020 4:29 AM EST

Wells Fargo analyst David Maris downgraded Allergen (NYSE: AGN) from Overweight to Equal Weight with a price target of $198.00.


For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.


Shares of Allergen closed at $192.58 yesterday.

... More